AMY BUCKNER: Open Payments
NPI 1669920807 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,050 in 132 payments from 25 companies in 2025. Trend: 2023 $2,133 · 2024 $2,252 · 2025 $2,050
Food & beverage: $2,050
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $398 |
| ABBVIE INC. | 40 | $368 |
| Novo Nordisk Inc | 13 | $240 |
| Lilly USA, LLC | 11 | $156 |
| GlaxoSmithKline, LLC. | 10 | $137 |
| Verona Pharma, Inc. | 7 | $99 |
| Abbott Laboratories | 4 | $96 |
| Otsuka America Pharmaceutical, Inc. | 5 | $73 |
| Astellas Pharma US Inc | 3 | $64 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $38 |
Products named: BREZTRI, Ozempic, VRAYLAR, MOUNJARO, REXULTI, Ohtuvayre, FREESTYLE LIBRE, QULIPTA.
Industry payments across MO — which companies pay providers there.
